Office-Based Treatment of Opioid-Dependent Patients
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
A 30-year-old man reports a two-year history of heroin use. For the past year, he has been using intranasal heroin every day. He has undergone detoxification twice at a local opioid-abuse treatment program but began using heroin within two days after discharge each time. He has heard of methadone but fears that he will lose his business if he is recognized attending the local program. How should this patient be treated?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment of OUD with B/N has been shown to be medically effective (increasing retention in treatment and decreasing use of illicit opioids) and cost-effective.3–8”
From Implementing Group Visits for Opioid Use Disorder: A Case Series (2020) · cites this paper as [6]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome
Ball, J. C., & Ross, A. O. (1991) · Cited by 903
The Effects of Psychosocial Services in Substance Abuse Treatment
McLellan, A. T. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500150065028 · Cited by 869
Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner, R. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130077015 · Cited by 746
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS).
Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997) · Psychology of Addictive Behaviors · doi:10.1037//0893-164x.11.4.261 · Cited by 602
The Effectiveness of Methadone Maintenance Treatment
Ball, J. C., & Ross, A. (1991) · Springer eBooks · doi:10.1007/978-1-4613-9089-3 · Cited by 590
Effective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
Metzger, D. S., WOODY, G. E., McLellan, A. T., O’Brien, C. P., Druley, P., Navaline, H. A., DePhilippis, D., Stolley, P. D., & Abrutyn, E. (1993) · PubMed · Cited by 530
Sees, K. L., Delucchi, K. L., Masson, C., Rosen, A., Clark, H. W., Robillard, H., Banys, P., & Hall, S. M. (2000) · JAMA · doi:10.1001/jama.283.10.1303 · Cited by 415
Methadone Maintenance Treatment and other Opioid Replacement Therapies
Hall, J. W. P. M. (1997) · Cited by 326
The effects of psychosocial services in substance abuse treatment
McLellan, A. T. (1993) · JAMA · doi:10.1001/jama.269.15.1953 · Cited by 248
Lapse, Relapse and Survival among Opiate Addicts after Treatment: A Prospective Follow-up Study
Gossop, M., Green, L., Phillips, G., & Bradley, B. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.3.348 · Cited by 230
Variations in methadone treatment practices. Results from a national study
D’Aunno, T. A. (1992) · JAMA · doi:10.1001/jama.267.2.253 · Cited by 230
Fudala, P. J., Jaffe, J. H., Dax, E. M., & Johnson, R. E. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.67 · Cited by 191
Pharmacologic Treatment of Heroin-Dependent Patients
O'Connor, P. G., & Fiellin, D. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00008 · Cited by 183
Self-citationMethadone Maintenance in Primary Care: A Randomized Controlled Trial
Fiellin, D. A., O'Connor, P. G., Chawarski, M., Pakes, J. P., Pantalon, M. V., & Schottenfeld, R. S. (2001) · JAMA · doi:10.1001/jama.286.14.1724 · Cited by 182
Self-citationThree Methods of Opioid Detoxification in a Primary Care Setting: A Randomized Trial
O'Connor, P. G., Carroll, K. M., Shi, J. M., Schottenfeld, R. S., Kosten, T. R., & Rounsaville, B. J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-7-199710010-00004 · Cited by 178
Self-citationO’Connor, P., Oliveto, A., Shi, J., Triffleman, E., Carroll, K., Kosten, T., Rounsaville, B., Pakes, J., & Schottenfeld, R. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00194-6 · Cited by 174
Self-citationRapid and Ultrarapid Opioid Detoxification Techniques
O'Connor, P. G. (1998) · JAMA · doi:10.1001/jama.279.3.229 · Cited by 170
Self-citationThe 1991 National Household Survey on Drug Abuse: (386502004-001)
Gfroerer, J., Sociometrics Corporation, Gustin, J., Virag, T., Folsom, R., & Rachal, J. V. (1991) · PsycEXTRA Dataset · doi:10.1037/e386502004-001 · Cited by 167
Strang, J., Sheridan, J. L., & Barber, N. (1996) · BMJ · doi:10.1136/bmj.313.7052.270 · Cited by 147
Withdrawal From Methadone Maintenance: Rate of Withdrawal and Expectation
Senay, E. C. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770150119014 · Cited by 117
Treatment of heroin dependence with buprenorphine in primary care
Fiellin, D. A., Pantalon, M. V., Pakes, J. P., O'Connor, P. G., Chawarski, M., & Schottenfeld, R. S. (2002) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-120002972 · Cited by 98
Self-citationAlternate-day dosing during buprenorphine treatment of opioid dependence
Amass, L., Bickel, W. K., Higgins, S. T., & Badger, G. J. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00848-5 · Cited by 90
Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing
Johnson, R. E., Eissenberg, T., Stitzer, M. L., Strain, E. C., Liebson, I. A., & Bigelow, G. E. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01189-7 · Cited by 87
Primary care-based ambulatory opioid detoxification
O’Connor, P. G., Waugh, M. E., Carroll, K. M., Rounsaville, B. J., Diagkogiannis, I. A., & Schottenfeld, R. S. (1995) · Journal of General Internal Medicine · doi:10.1007/bf02599882 · Cited by 78
Self-citationA 12‐Year Follow‐Up of a Methadone Medical Maintenance Program
Schwartz, R. P., Brooner, R. K., Montoya, I. D., Currens, M., & Hayes, M. (1999) · The American Journal on Addictions · doi:10.1080/105504999305695 · Cited by 70
Novick, D. M., Joseph, H., Salsitz, E. A., Kalin, M. F., Keefe, J. B., Miller, E. L., & Richman, B. L. (1994) · Journal of General Internal Medicine · doi:10.1007/bf02600025 · Cited by 65
Salsitz, E. A., Joseph, H., Frank, B., Perez, J., Richman, B. L., Salomon, N., Kalin, M. F., & Novick, D. M. (2000) · PubMed · Cited by 57
Buprenorphine for opiate addiction: potential economic impact
Rosenheck, R. A., & Kosten, T. R. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00214-3 · Cited by 56
Vignau, J., & Brunelle, E. (1998) · European Addiction Research · doi:10.1159/000052038 · Cited by 48
NONPHARMACOLOGIC APPROACHES TO SUBSTANCE ABUSE TREATMENT
Carroll, K. M., & Schottenfeld, R. S. (1997) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70556-3 · Cited by 44
Effects of urine testing frequency on outcome in a methadone take-home contingency program
Chutuape, M. A., Silverman, K., & Stitzer, M. L. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00160-5 · Cited by 43
Senay, E. C., Barthwell, A. G., Marks, R., Bokos, P. J., Gillman, D., White, R., & Pristach, C. A. (1993) · Journal of Addictive Diseases · doi:10.1300/j069v12n04_05 · Cited by 30
Year-End 1997 Emergency Department Data From the Drug Abuse Warning Network
Kissin, W. (1999) · PsycEXTRA Dataset · doi:10.1037/e481642006-001 · Cited by 27
Moderate- vs High-Dose Methadone in the Treatment of Opioid Dependence: A Randomized Trial
Strain, E. C., Bigelow, G. E., Liebson, I. A., & Stitzer, M. L. (1999) · JAMA · doi:10.1001/jama.281.11.1000 · Cited by 6
Research works printed but not linked: 8
- 2001, Fed Regist, 66, 4076
- 2002, Fed Regist, 67, 13114
- AMA home page. Chicago: American Medical Association, 2002. (Accessed August 19, 2002, at http://www.ama-assn.org/.)
- Gowing L, 2000, Cochrane Database Syst Rev, 2, CD002021
- 10.1037/0893-164X.11.4.261 · DOI · Paper page
- Metzger DS, 1993, J Acquir Immune Defic Syndr, 6, 1049
- Salsitz EA, 2000, Mt Sinai J Med, 67, 388
- National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. Bethesda, Md.: National Institutes of Health, 1998. (Accessed August 19, 2002, at http://odp.od.nih.gov/consensus/cons/108/108_intro.htm.) · DOI · Paper page
Cited by
Management of Drug and Alcohol Withdrawal
Kosten, T. R., & O'Connor, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020617 · Cited by 563
Self-citationCamí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
Acute Pain Management for Patients Receiving Maintenance Methadone or Buprenorphine Therapy
Alford, D. P., Compton, P., & Samet, J. H. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-2-200601170-00010 · Cited by 468
Opioid dependence and addiction during opioid treatment of chronic pain
Ballantyne, J. C., & LaForge, S. K. (2007) · Pain · doi:10.1016/j.pain.2007.03.028 · Cited by 447
Dhalla, I. A., Mamdani, M. M., Sivilotti, M. L. A., Kopp, A., Qureshi, O., & Juurlink, D. N. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090784 · Cited by 438
Metadata
- Authors
- Fiellin, D. A., & O'Connor, P. G.
- Affiliations
- Yale University (US)
- ORCID
- Fiellin, David A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-09-12
- Volume
- 347
- Issue
- 11
- Pages
- 817-823
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2092853006
- Cited by
- 148
- References
- 36
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 8 · 2016: 4 · 2015: 6 · 2014: 7 · 2013: 5 · 2012: 4
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (K12DA000167)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- opioid use disorder, heroin use, office-based treatment, methadone maintenance treatment, opioid detoxification, opioid use disorder treatment
- MeSH terms
- Adult, Drug and Narcotic Control, Heroin Dependence, Humans, Male, Methadone, Opioid-Related Disorders, Narcotics, Rehabilitation, United States, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.